The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
from Top Health News -- ScienceDaily https://ift.tt/2q9ZS4D
No comments:
Post a Comment